106 related articles for article (PubMed ID: 22064117)
21. Metastatic parotid tumor: a rare presentation for papillary carcinoma of thyroid.
Malhotra G; Nair N; Awasare S; Baghel NS
Clin Nucl Med; 2007 Jun; 32(6):488-90. PubMed ID: 17515766
[No Abstract] [Full Text] [Related]
22. Differentiated thyroid cancer with epiphora: detection of nasolacrimal duct obstruction on I-131 SPECT/CT.
Yuoness S; Rachinsky I; Driedger AA; Belhocine TZ
Clin Nucl Med; 2011 Dec; 36(12):1149-52. PubMed ID: 22064099
[No Abstract] [Full Text] [Related]
23. Usefulness of (99m)Tc-pertechnetate whole body scan with neck and chest SPECT/CT for detection of post-surgical thyroid remnant and metastasis in differentiated thyroid cancer patients.
Chantadisai M; Kingpetch K
Ann Nucl Med; 2014 Aug; 28(7):674-82. PubMed ID: 24889127
[TBL] [Abstract][Full Text] [Related]
24. Hürthle cell lesions of the thyroid gland.
Thompson NW; Dunn EL; Batsakis JG; Nishiyama RH
Surg Gynecol Obstet; 1974 Oct; 139(4):555-60. PubMed ID: 4479589
[No Abstract] [Full Text] [Related]
25. Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma.
Lee HJ; Rha SY; Jo YS; Kim SM; Ku BJ; Shong M; Kim YK; Ro HK
Am J Clin Oncol; 2007 Feb; 30(1):63-8. PubMed ID: 17278897
[TBL] [Abstract][Full Text] [Related]
26. Nuclear medicine in the assessment of differentiated thyroid cancer.
Rutherford GC; Franc B; O'Connor A
Clin Radiol; 2008 Apr; 63(4):453-63. PubMed ID: 18325367
[TBL] [Abstract][Full Text] [Related]
27. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
[TBL] [Abstract][Full Text] [Related]
28. Outline for the treatment of differentiated thyroid carcinomas by total thyroidectomy and complementary radioiodine.
Savoie JC; Massin JP
Ann Radiol (Paris); 1977; 20(8):822-5. PubMed ID: 610556
[No Abstract] [Full Text] [Related]
29. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
30. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning.
Dam HQ; Kim SM; Lin HC; Intenzo CM
Radiology; 2004 Aug; 232(2):527-33. PubMed ID: 15286323
[TBL] [Abstract][Full Text] [Related]
31. [Scintigraphy using 131I in oxyphilic carcinomas of the thyroid gland].
Hamann A; Gratz KF; Soudah B; Fritsch RS; Hundeshagen H
Nuklearmedizin; 1994 Oct; 33(5):219-23. PubMed ID: 7997381
[TBL] [Abstract][Full Text] [Related]
32. Anaplastic carcinoma of the thyroid.
Kyriakides G; Sosin H
Ann Surg; 1974 Mar; 179(3):295-9. PubMed ID: 4813476
[No Abstract] [Full Text] [Related]
33. Retro-orbital metastasis from differentiated thyroid carcinoma in a radioiodine therapy-naïve patient: any lesson learned?
Okere PC; Tushar M
Med Princ Pract; 2012; 21(6):579-81. PubMed ID: 22678126
[TBL] [Abstract][Full Text] [Related]
34. [Differentiated thyroid cancers].
Gorgone S; Campennì A; Calbo E; Catalfamo A; Sciglitano P; Sofia L; Niceta M; Borzì R; Calbo L
G Chir; 2009; 30(1-2):26-9. PubMed ID: 19272228
[TBL] [Abstract][Full Text] [Related]
35. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
[TBL] [Abstract][Full Text] [Related]
36. The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer.
Grewal RK; Tuttle RM; Fox J; Borkar S; Chou JF; Gonen M; Strauss HW; Larson SM; Schöder H
J Nucl Med; 2010 Sep; 51(9):1361-7. PubMed ID: 20720058
[TBL] [Abstract][Full Text] [Related]
37. [Incidental detection of a papillary thyroid cancer by ¹⁸F-FDG PET-CT study in a patient with metastatic colorectal cancer].
Banzo J; Ubieto MA; Villalta J; Razola P; Prats E; Andrés A
Rev Esp Med Nucl; 2010; 29(6):312-3. PubMed ID: 20826040
[No Abstract] [Full Text] [Related]
38. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
[TBL] [Abstract][Full Text] [Related]
40. [Non-surgical treatment of thyroid neoplasms].
Klepp O
Tidsskr Nor Laegeforen; 1975 Aug; 95(23):1287-90. PubMed ID: 1179338
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
